Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Vor Biopharma Inc (NQ: VOR )

2.160 -0.020 (-0.92%)
Streaming Delayed Price Updated: 4:00 PM EDT, Sep 22, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 51,459
Open 2.190
Bid (Size) 2.000 (1)
Ask (Size) 2.200 (6)
Prev. Close 2.180
Today's Range 2.125 - 2.220
52wk Range 2.100 - 7.570
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Stocks That Hit 52-Week Lows On Thursday
  During the session on Thursday, 461 stocks hit new 52-week lows. 
Via Benzinga
The Latest Analyst Ratings for Vor Biopharma
Via Benzinga

Performance

YTD
-68.05%
-68.05%
1 Month
-21.74%
-21.74%
3 Month
-38.90%
-38.90%
6 Month
-61.57%
-61.57%
1 Year
-50.46%
-50.46%

More News

Read More
What 11 Analyst Ratings Have To Say About Vor Biopharma
Via Benzinga
8 Analysts Have This to Say About Vor Biopharma
Via Benzinga
Vor Biopharma: Q1 Earnings Insights
Via Benzinga
Stocks That Hit 52-Week Lows On Tuesday
Via Benzinga
Vor Bio to Participate in Upcoming Investor Conferences
From Vor Biopharma
Via GlobeNewswire
Where Vor Biopharma Stands With Analysts
Via Benzinga
Truist Securities Maintains Buy Rating for Vor Biopharma: Here's What You Need To Know
Via Benzinga
Stocks That Hit 52-Week Lows On Friday
Via Benzinga
Vor Bio Reports Second Quarter 2023 Financial Results and Provides Company Update
From Vor Biopharma
Via GlobeNewswire
Stocks That Hit 52-Week Lows On Thursday
Via Benzinga
Vor Bio to Participate in the Wedbush PacGrow Healthcare Conference
From Vor Biopharma
Via GlobeNewswire
Stocks That Hit 52-Week Lows On Wednesday
Via Benzinga
Top 5 Health Care Stocks That Could Lead To Your Biggest Gains In July
Via Benzinga
Vor Bio's Trem-cel Shows Early Encouraging Data In Leukemia Patients
Via Benzinga
Successful Primary Engraftment of Trem-cel in First Five AML Patients Demonstrates Promise of Vor Bio’s Platform
From Vor Biopharma
Via GlobeNewswire
Vor Bio to Participate in the Goldman Sachs Healthcare Conference
From Vor Biopharma
Via GlobeNewswire
Benzinga's Top Ratings Upgrades, Downgrades For May 16, 2023
Via Benzinga
Vor Bio Reports First Quarter 2023 Financial Results and Provides Company Update
From Vor Biopharma
Via GlobeNewswire
Vor Bio to Participate in Upcoming Investor Conferences
From Vor Biopharma
Via GlobeNewswire
Dow Rises 50 Points; Oxford Industries Shares Plunge
Via Benzinga
Why Scholastic Shares Are Trading Lower By 23%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Via Benzinga
Vor Bio Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Company Update
From Vor Biopharma
Via GlobeNewswire
Vor Bio to Participate in Upcoming Investor Conferences
From Vor Biopharma
Via GlobeNewswire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.